Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsEven years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.
In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.
Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.
Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.
Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.
1.
Study opens up possibility of bespoke prostate cancer treatment
2.
Why Encouragement May Not Improve Motivation in Depression
3.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
4.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
5.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
1.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
2.
Patient Management for Bone Marrow Functional Recovery Pathways
3.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
4.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
5.
Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Early Cancer Detection Saves Lives
5.
How Platelet Disorders Can Affect the Body
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation